| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $493K | -48.4% |
| SG&A Expense | $2.6M | -10.9% |
| Operating Income | -$3.1M | +20.1% |
| Net Income | -$2.4M | +49.0% |
| EPS (Basic) | -$0.08 | +55.6% |
| EPS (Diluted) | -$0.08 | +55.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $4.7M | — |
| Total Assets | $6.2M | +4074.1% |
| Current Liabilities | $2.0M | -65.2% |
| Total Liabilities | $2.0M | -65.9% |
| Stockholders' Equity | $4.2M | +171.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.9M | -713.2% |
| Financing Cash Flow | $7.7M | +1619.6% |